Investment banks earned over Rs 1,000 crore in underwriting fees during July and August 2026, a sharp rise from the first quarter. This surge is driven by companies rushing to launch IPOs before a critical SEBI deadline on September 30. Investors should watch how the market absorbs the remaining pipeline of over 160 companies.
Indian investment banks have seen a massive spike in earnings from underwriting fees, raking in over Rs 1,000 crore during July and August 2026. This performance marks a significant jump compared to the first quarter of the year, when total fees across new listings amounted to only Rs 132.90 crore. The sudden increase in activity reflects a busy period for the primary market as companies accelerate their public offering plans.
The primary driver behind this wave of listings is a regulatory deadline. Many companies had previously received approval from the Securities and Exchange Board of India (SEBI) to launch their IPOs but had delayed their plans. With the regulator setting a September 30, 2026, deadline for these approvals to expire, issuers have been rushing to hit the market. This regulatory bottleneck has forced a compressed timeline for companies that had been waiting for favourable market conditions.
The scale of this rush is visible in the fundraising numbers. July and August saw 33 companies launch their IPOs, raising approximately Rs 49,592 crore. This accounts for the vast majority of the total fundraising seen in the first eight months of 2026. Large-ticket listings have been central to the revenue pool for investment banks. For instance, Manipal Health Enterprises contributed significantly to the total, with disclosed fees of over Rs 165 crore, while other offerings like Dhoot Transmission also added to the fee generation.
Domestic mutual funds are playing a central role in sustaining this high level of activity. Steady money flowing into these funds is forcing managers to look for new investment opportunities, which provides a steady source of demand for incoming IPOs. However, the market environment is shifting. It is no longer a case of investors blindly accepting every offer. As the supply of new shares increases, issuers are increasingly being forced to trim their issue sizes and adjust valuations to ensure they attract enough interest.
Looking ahead, the primary monitorable for investors is the massive remaining pipeline. There are currently over 160 companies holding valid SEBI approvals with the potential to raise over Rs 4 lakh crore. This creates a risk of supply saturation. If the pace of new listings continues to be this high, investor appetite could face pressure, especially if market sentiment is impacted by external factors like geopolitical tensions. The crucial update for the coming weeks will be how the market manages these incoming offers before the September 30 deadline passes, and whether quality and pricing remain the focus for institutional investors.